• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ROCHE CARDIAC D-DIMER; FIBRINOGEN AND FIBRIN SPLIT PRODUCTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ROCHE CARDIAC D-DIMER; FIBRINOGEN AND FIBRIN SPLIT PRODUCTS Back to Search Results
Catalog Number 04877802190
Device Problem Low Test Results (2458)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/02/2018
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).Unique identifier (udi)#: (b)(4).
 
Event Description
The customer complained of discrepant results for 1 patient sample tested for roche cardiac d-dimer between two h232 instruments.The initial d-dimer result from a venous sample on h232 instrument serial number (b)(4) was 0.6 (unit of measure not provided)."almost simultaneously," the sample was repeated on a second h232 instrument and the result was 1.5.The internal qc failed on h232 instrument with serial number (b)(4) so the customer thinks the result of 0.6 is incorrect.The internal qc for the second h232 instrument passed.The patient was not adversely affected.The cobas h232 instrument nor a similar device is approved for distribution in the united states.The instrument and test strips were requested for investigation.
 
Manufacturer Narrative
The customer did not return the meter or the test strips.As no product was returned, the investigation could not be completed.The investigation was unable to find a definitive root cause.
 
Manufacturer Narrative
Relevant retention material roche cardiac d-dimer of lot 25712710 was measured on a cobas h232 at the investigation site with: two native blood samples and two spiked blood samples (c=0.60 g/ml and c=1.5 g/ml), each blood sample n=three test strips.Mean of the measurements on the cobas h232 at the investigation site: first native blood sample: 0.31 g/ml.Second native blood sample: 0.16 g/ml.First spiked blood sample (c=0.60 g/ml): 0.55 g/ml.Second spiked blood sample (c=1.5 g/ml): 1.30 g/ml.The results of all the measurements meet the requirements.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROCHE CARDIAC D-DIMER
Type of Device
FIBRINOGEN AND FIBRIN SPLIT PRODUCTS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7429223
MDR Text Key106039615
Report Number1823260-2018-01152
Device Sequence Number1
Product Code GHH
Combination Product (y/n)N
PMA/PMN Number
K033491
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 05/23/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number04877802190
Device Lot Number25712711
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/02/2018
Initial Date FDA Received04/13/2018
Supplement Dates Manufacturer Received04/02/2018
04/02/2018
Supplement Dates FDA Received05/01/2018
05/23/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-